Navigation Links
New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients
Date:11/1/2008

ocytopenic purpura, psoriasis, lupus, rheumatoid arthritis and interstitial nephritis), pulmonary disorders (dyspnea, pneumonia, bronchiolitis obliterans, interstitial pneumonitis and sarcoidosis), colitis (ulcerative and hemorrhagic/ischemic colitis), pancreatitis, and ophthalmologic disorders (decrease or loss of vision, retinopathy including macular edema and retinal thrombosis/hemorrhages, optic neuritis and papilledema). Adverse reactions reported during post-approval use of PEGASYS therapy, with and without ribavirin, include hearing impairment, hearing loss, serious skin reactions, including erythema multiforme major, and infections (bacterial, viral and fungal).

About Roche

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche has been committed to developing innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. For additional information about the U.S. pharmaceuticals business, visit our website http://www.rocheusa.com. Product and treatment information for U.S. healthcare professionals is available at http://www.RocheExchange.com.

All trademarks used or mentioned in this release are protected by law.

PegIntronTM is a trademark product of Schering Plough Corporation.

(1) Rumi M, Aghemo A, Prati G, et al. Randomized study comparing peginterferon-alfa-2a plus ribavirin and peginterferon-alfa-2b plus ribavirin in naive patients with chronic hepatitis C: final results of the Milan Safety Tolerability Study. Abstract presented at the American Association for the Study of Liver Disease; 31 October 2008; San Fr
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. New International Study Shows Women With Symptomatic Fibroids Delaying Treatment Despite Substantial Burden on Quality of Life
2. Study Found That Long Term Use of Advair Diskus(R) 250/50 Did Not Adversely Affect Bone Loss in Patients with COPD
3. Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD
4. Grapes May Aid a Bunch of Heart Risk Factors, U-M Animal Study Finds
5. NCI Funded Clinical Trial to Study Treatment of Breast Cancer Using Cryoablation
6. Nuvo Research presents positive Phase III study results for Pennsaid at leading rheumatology conference
7. Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus
8. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
9. Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults
10. New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
11. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 1, 2015 Semler Scientific, Inc. ... company that develops, manufactures and markets products that assist ... today reported financial results for the first quarter ended ... quarter of 2015, Semler reported continued progress with year ... quarter revenue growth of 14%," said Doug Murphy-Chutorian ...
(Date:5/1/2015)...  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ), a specialty ... innovative therapies for the treatment of acute and breakthrough ... chief financial officer  will be participating in three upcoming ... Mizuho Third Annual Healthcare Corporate Access Day ... New York Bank ...
(Date:5/1/2015)... May 1, 2015  Shares of Aerie Pharmaceuticals, Inc. ... value yesterday following the results of the Phase 3 ... Despite the trial failing to meet its end points, ... may come from future studies. An analyst ... current pipeline, financial review, analyst summary, valuation, and recommendation ...
Breaking Medicine Technology:Semler Reports First Quarter 2015 Financial Results 2Semler Reports First Quarter 2015 Financial Results 3Semler Reports First Quarter 2015 Financial Results 4Semler Reports First Quarter 2015 Financial Results 5AcelRx Pharmaceuticals to Participate at Upcoming Investor Conferences in May 2All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2
... , ALISO VIEJO, Calif., Nov. 17 OCTANe hosted ... companies to discuss promising technology and emerging trends for the ... Medical Device & Investor Forum. , For the first ... transactions in Orange County history discussed the details of the ...
... , NEW YORK, Nov. 17 Engineer/pilot/attorney Jon Roberts, ... They include technology that thwarts piracy in movie theatres, ... to enhance airport security and even an electronic matchmaker ... they have, indeed, found their match. Now, as ...
Cached Medicine Technology:OCTANe's Medical Device & Investor Forum Highlights Key Trends, Investment Opportunities 2When Viruses (Including H1N1) and Bacteria are as Close as your Fingertips; VirWall's New Innovation Can Disarm Killer Keyboards 2
(Date:5/2/2015)... (PRWEB) May 02, 2015 ZoomCare, the ... has submitted plans to offer its new healthcare insurance ... The ZOOM+ Personal Health Insurance System is the nation’s ... to enhance human performance. ZOOM+ Personal Health Insurance was ... delivery system that are subject to review and regulation ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 Pioneer Millworks, ... share the latest in their reclaimed wood products at ... the Jacob Javits Center in NYC this May. Their ... will bring much anticipated texture and color to North ... an explosion of texture and color in the design ...
(Date:5/1/2015)... Mesa, CA (PRWEB) May 01, 2015 ... at the Cerner Southeast Regional User Group (RUG) Conference ... The Cerner Southeast Regional User Group Conference provides a ... to vendors who support all aspects of electronic medical ... use of Cerner software applications. , In addition to ...
(Date:5/1/2015)... CA (PRWEB) May 01, 2015 The ... genetic makeup and the interplay of genes with one ... with developments can be daunting. , LabRoots, the premier ... clinical diagnostics professionals, will soon host its annual conference ... At BioConference Live Genetics and Genomics 2015 , ...
(Date:5/1/2015)... Digital technology and Wi-Fi-enabled medical equipment may ... appointments, a preliminary study has shown. ... low-risk pregnant women, will be presented as a poster ... Associates at the 2015 American Congress of Obstetricians and ... The digital technology used was developed by Babyscripts™ ...
Breaking Medicine News(10 mins):Health News:ZoomCare Applies to be on Oregon Exchange 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 3Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 3Health News:Mobile Technology May Be Effective in Monitoring Pregnant Women Between Office Visits, Study Shows 2Health News:Mobile Technology May Be Effective in Monitoring Pregnant Women Between Office Visits, Study Shows 3
... comes to estimating calorie counts, Americans aren,t really on ... Journal of Consumer Research , this may be ... food. "The sequence in which items are considered ... Alexander Chernev (Northwestern University). "The focus on sequential estimation ...
... By Kathleen Doheny HealthDay Reporter ... new studies may help breast cancer patients and ... reconstruction after mastectomy. One study finds that ... after having had a mastectomy with immediate reconstruction ...
... ultimate goal to discover a drug that one day treats ... on pinpointing the mechanisms in the brain that respond to ... in the UH College of Pharmacy, received a three-year, $450,000 ... In the end, his team hopes their research will help ...
... of prostate tumors, promotes the growth of a different type ... online on September 20 in the Journal of Experimental ... and colleagues find that TAL1, a protein abundantly expressed in ... (T-ALL), drives expression of NKX3.1. Eliminating NKX3.1 halted the ...
... might not benefit from some of the tuberculosis vaccines currently ... are designed to activate a specific molecule that is an ... people. But a recent Ohio State University study suggests that ... the face of TB infection. The animal research suggests ...
... of Utah determined that the 2009 pandemic influenza A ... children than the seasonal flu. The most common ... of the study, the most extensive evaluation of neurological ... the September issue of Annals of Neurology , ...
Cached Medicine News:Health News:Low-calorie cheesecake? Why we have trouble estimating calories 2Health News:Breast Reconstruction After Mastectomy: Now or Later? 2Health News:Breast Reconstruction After Mastectomy: Now or Later? 3Health News:Drug to treat alcoholism goal of UH professor's research 2Health News:Elderly might not benefit from TB vaccines in development 2Health News:Elderly might not benefit from TB vaccines in development 3Health News:Higher incidence of seizures seen in children with H1N1 virus compared to seasonal flu 2
Integra Epilepsy grid electrodes are thin and flexible for easier placement and to conform to the curvature of the cortical surface. Lead tunneling is done using a 14-gauge tunneling needle (ET-2)....
...
... Electrodes feature exceptional quality and design to ... seizure recording technology. Neurosurgeons worldwide consider these ... flexible available. Our electrodes come in many ... 4-contact strips to 64-contact grids. Their bodies ...
... designed for laboratories looking for time and ... system operation in terms of easy reagent ... and on-board stability., ,URISYS 2400 is ... walk-away capability for medium to high volume ...
Medicine Products: